Moreover, this cancer-related decrease in serum GKN1 was more evident in advanced GC patients than in early GC patients, with GKN1 diagnostic accuracies at the optimum cut-off (0.9675) of 0.8912 and 0.9589 for early GC and advanced GC, respectively. The gene discussed is GKN1; the disease is gastric cancer.